Artificial intelligence to accurately identify breast cancer patients with a pathologic complete response for omission of surgery after neoadjuvant systemic therapy: An international multicenter analysis.

被引：0
|
作者：
Pfob, Andre
Sidey-Gibbons, Chris
Tasoulis, Marios Konstantinos
Lee, Han-Byoel
Koelbel, Vivian
Kuerer, Henry Mark
Heil, Joerg
机构：
[1] Univ Hosp Heidelberg, Dept Obstet & Gynecol, Heidelberg, Germany
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Royal Marsden NHS Fdn Trust, London, England
[4] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
[5] Univ Texas MD Anderson Canc Ctr, NRG Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
565
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Artificial intelligence to accurately identify and select breast cancer patients with a pathologic complete response for omission of surgery after neoadjuvant systemic therapy: an international multicenter analysis
    Pfob, A.
    Sidey-Gibbons, C.
    Tasoulis, M. K.
    Lee, H. B.
    Koelbel, V
    Kuerer, H. M.
    Heil, J.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E88 - E88
  • [2] Intelligent vacuum-assisted breast biopsy to identify breast cancer patients with pathologic complete response after neoadjuvant systemic treatment for omission of breast and axillary surgery
    Pfob, Andre
    Sidey-Gibbons, Chris
    Rauch, Geraldine
    Thomas, Bettina
    Schaefgen, Benedikt
    Kuemmel, Sherko
    Reimer, Toralf
    Hahn, Markus
    Thill, Marc
    Blohmer, Jens-Uwe
    Hackmann, John
    Malter, Wolfram
    Bekes, Inga
    Friedrichs, Kay
    Wojcinski, Sebastian
    Joos, Sylvie
    Paepke, Stefan
    Degenhardt, Tom
    Rom, Joachim
    Rody, Achim
    Grosse, Regina
    van Mackelenbergh, Marion
    Reinisch, Mattea
    Karsten, Maria
    Golatta, Michael
    Heil, Joerg
    CANCER RESEARCH, 2022, 82 (04)
  • [3] Can MRI accurately identify which patients with operable breast cancer will have a pathologic complete response after neoadjuvant therapy?
    Nessim, Carolyn
    Trop, Isabelle
    Robidoux, Andre
    Mamounas, Eleftherios P.
    Boileau, Jean-Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial
    Jung, Ji-Jung
    Cheun, Jong-Ho
    Kim, Soo-Yeon
    Koh, Jiwon
    Ryu, Jai Min
    Yoo, Tae-Kyung
    Shin, Hee-Chul
    Ahn, Sung Gwe
    Park, Seho
    Lim, Woosung
    Nam, Sang-Eun
    Park, Min Ho
    Kim, Ku Sang
    Kang, Taewoo
    Lee, Jeeyeon
    Youn, Hyun Jo
    Kim, Yoo Seok
    Yoon, Chang Ik
    Kim, Hong-Kyu
    Moon, Hyeong-Gon
    Han, Wonshik
    Cho, Nariya
    Kim, Min Kyoon
    Lee, Han-Byoel
    JOURNAL OF BREAST CANCER, 2024, 27 (01) : 61 - 71
  • [5] Omission of breast surgery in selected breast cancer patients with excellent response to neoadjuvant systemic therapy
    Tasoulis, Marios-Konstantinos
    Muktar, Samantha
    Smith, Ian
    Roche, Nicola
    Macneill, Fiona
    EJSO, 2024, 50 (06):
  • [6] Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery
    Tadros, Audree B.
    Yang, Wei T.
    Krishnamurthy, Savitri
    Rauch, Gaiane M.
    Smith, Benjamin D.
    Valero, Vicente
    Black, Dalliah M.
    Lucci, Anthony, Jr.
    Caudle, Abigail S.
    DeSnyder, Sarah M.
    Teshome, Mediget
    Barcenas, Carlos H.
    Miggins, Makesha
    Adrada, Beatriz E.
    Moseley, Tanya
    Hwang, Rosa F.
    Hunt, Kelly K.
    Kuerer, Henry M.
    JAMA SURGERY, 2017, 152 (07) : 665 - 670
  • [7] Identifying determinants of pathologic complete response in patients with breast cancer after receiving neoadjuvant systemic therapy
    Chan, Abigail Sy
    Bhargava, Anika
    Chandler, Natasha
    Tavcar, Michelle
    Gunaratnam, Bakeerathan
    Dong, Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] owards omitting breast cancer surgery in patients with pathologic complete response after neoadjuvant systemic therapy: The MICRA trial (minimally invasive complete response assessment)
    van der Noordaa, M. E.
    van Duijnhoven, F. H.
    Loo, C. E.
    van Loevezijn, A.
    van Werkhoven, E.
    van de Vijver, K. K.
    Wiersma, T.
    Winter-Warnars, H. A.
    Sonke, G. S.
    Peeters, M-J T. Vrancken
    CANCER RESEARCH, 2019, 79 (04)
  • [9] Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery
    Pfob, Andre
    Sidey-Gibbons, Chris
    Rauch, Geraldine
    Thomas, Bettina
    Schaefgen, Benedikt
    Kuemmel, Sherko
    Reimer, Toralf
    Hahn, Markus
    Thill, Marc
    Blohmer, Jens-Uwe
    Hackmann, John
    Malter, Wolfram
    Bekes, Inga
    Friedrichs, Kay
    Wojcinski, Sebastian
    Joos, Sylvie
    Paepke, Stefan
    Degenhardt, Tom
    Rom, Joachim
    Rody, Achim
    van Mackelenbergh, Marion
    Banys-Paluchowski, Maggie
    Grosse, Regina
    Reinisch, Mattea
    Karsten, Maria
    Golatta, Michael
    Heil, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17) : 1903 - +
  • [10] The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response
    Mandish, Steven F.
    Gaskins, Jeremy T.
    Yusuf, Mehran B.
    Amer, Yomna M.
    Eldredge-Hindy, Harriet
    ACTA ONCOLOGICA, 2020, 59 (10) : 1210 - 1217
12345